Phase II trial of DM-199 for the treatment of chronic kidney disease
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2019
At a glance
- Drugs DM 199 (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 03 Jan 2019 According to a DiaMedica Therapeutics media release, the company expects to complete this study in in Q4 2019 or Q1 2020.
- 03 May 2018 According to a DiaMedica Therapeutics media release, the company is preparing to file an IND as per guidance received from the FDA during a type-B meeting and expects to initiate this trial in second half of 2018.
- 23 Jan 2018 New trial record